Effects of Iloprost on Hypoxic Pulmonary Vasoconstriction and Exercise Capacity at High Altitude

NCT00708565 is an interventional clinical trial that is for Hypoxic Pulmonary Vasoconstriction conditions and was started in July of 2008. This trial has 50 people enrolled who are within the adult and senior age range. This trial is funded by a United States federal agency, and an industry organization. The specific sponsors / contributors of this trial are as follows: VA Loma Linda Health Care System, and Actelion. The following interventions were used in this trial: (drug) Iloprost. This trial is reported / scheduled to have been completed in October of 2008.

Other clinical trials

• Feasibility Study of Take-Home LAAM Medication - 3
• Cocaine Effects in Humans: Physiology and Behavior - 1
• Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up
• Alendronate and/or Parathyroid Hormone for Osteoporosis
• Methadone Effects on Zidovudine (ZDV, AZT) Disposition

Other Pages ...

• Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma
• A Study Comparing Ceramic-on-Metal Articulation to Metal-on-Metal Articulation in Cementless Primary Hip Arthroplasty
• Efficacy and Safety Study of DERMAGEN® vs Conventional Treatment to Treat Diabetic Neuropathic Foot Ulcer
• IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria.
• Having Sex with a Dead Deer is Illegal